washingtonpost.com: Big Pharma abuses FDA petition procedure for gain

Petitions to FDA Sometimes Delay Generic Drugs
By Marc Kaufman

A procedure designed to alert the Food and Drug Administration to scientific and safety issues is getting a hard look from members of Congress, who say they are concerned that it may be getting subverted by the brand-name drug industry.

To view the entire article, go to http://www.washingtonpost.com/wp-dyn/content/article/2006/07/02/AR2006070200840.html?referrer=emailarticle